Literature DB >> 2886094

Immunomodulatory action of somatostatin.

M Pawlikowski, H Stepień, J Kunert-Radek, P Zelazowski, A V Schally.   

Abstract

The influence of somatostatin (SST) on spontaneous proliferation and cyclic AMP level in mouse spleen lymphocytes and on inhibition of human leukocyte migration was studied. The rate of [3H]thymidine incorporation was used as an index of proliferation. It was found that lower concentrations of SST/10(-9) and 10(-8)M, inhibited the splenocyte proliferation. In contrast, a higher SST concentration, 10(-7)M, exerted a stimulatory effect. SST in concentrations from 10(-9) to 10(-6)M did not influence cyclic AMP levels in mouse splenocytes; a significant decrease of cyclic AMP was found after the exposure to superactive SST analog RC-102-2H in concentrations 10(-8) and 10(-7)M. SST, 10(-7)M, and RC-102-2H, 10(-7)M, significantly enhanced the migration inhibition of human leukocytes induced by the exposure of leukocytes to cardiac antigen or phytohemagglutinin. The data provide evidence for an immunomodulatory action of SST.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2886094     DOI: 10.1111/j.1749-6632.1987.tb35771.x

Source DB:  PubMed          Journal:  Ann N Y Acad Sci        ISSN: 0077-8923            Impact factor:   5.691


  4 in total

1.  Measles virus modulates human T-cell somatostatin receptors and their coupling to adenylyl cyclase.

Authors:  S Krantic; A Enjalbert; C Rabourdin-Combe
Journal:  J Virol       Date:  1997-10       Impact factor: 5.103

Review 2.  A rare case of primary skeletal muscle lymphoma: the value of octreotide scintigraphy.

Authors:  C Heuschling; F A Houssiau; F Jamar; H Noel; J P Devogelaer; C Nagant de Deuxchaisnes
Journal:  Clin Rheumatol       Date:  1995-05       Impact factor: 2.980

3.  Octreotide regulates CC but not CXC LPS-induced chemokine secretion in rat Kupffer cells.

Authors:  Vassilis Valatas; George Kolios; Pinelopi Manousou; George Notas; Costas Xidakis; Ioannis Diamantis; Elias Kouroumalis
Journal:  Br J Pharmacol       Date:  2004-01-12       Impact factor: 8.739

4.  Somatostatin in inflammatory bowel disease.

Authors:  J D van Bergeijk; J H Wilson
Journal:  Mediators Inflamm       Date:  1997       Impact factor: 4.711

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.